Tobacco Documents Online

r~- ~ t t s (~,. f ~~.~• These drugs were recalled from the market between July 30 and Aug. 12. Each paragraph gives: Name and form of the product; name of manufac- turer and/or distributor; reason for recall; lot numbers involved. Asterisk after the monufacturer's name indicates that the recall was initiated by him.  ACTH Gel for intramuscular use in 5 ml multiple dose vials. 80 units per m] (National Drug* I ... sub-potent ... 6358A9.  All Naturalvile multi-Vit mineral prep in vita-tabs & Advantage Multi-Vit. mineral prep in tabs. (Tennehill Pharm.* I... Sub-potent %super-potent •.. 03147-1 & 031-17-6.  Arno T.+el."e w"Hi-B. 10 cc. (,t1laizel Labs.-Distr.: Arno Labs.* 1... Sub• potent ... L1239.  Baromycin antibiotic 1/2 oz. (,9rnbix Labs.* ) ... Sub-potent ... 1640.  B-Complex .+'B-12 Plus. 10 cc. (MaizPl Labs.-Mfg. for 1Llisemer Pharm.* i . Sub-potent ... L12 ;9.  B-Complex w Vit. B-12. 10 '.NSL (Maizel Labs.-Mfg. for It erner Labs." i Sub-potent . . . L1239.  B-Complex w'Vit. B-12 Multi Vit. fnj. in vial, 10 cc (.'llaize! Labs.-Di-tr.: Barnard Co.* ) Sub-potent ... L1239.  B-Complex w \'it. B-12. 10 cc (Maizel Labs.-Mfg. for Leicy's Steubent•illc* ) . Sub-potent ... L1239.  Dextro-amphetamine sulfate. 5 mg. tabs. (Plymouth Labs.-Distr.: Pharmecon Labs.* ) ... Sub-potent ... 101-11.  Duo-'tled Androgen Estrogen susp. in 10 cc. vial• (Myers-Carter Labs.-Distr.: .t1lPdics Pharm.* I ... Super-potent ... 0A007.  Epinephrine as. Borate complex opthalmic so1. in bots. (Alcon Labs.* )... Label mix-up ... RFM & RF11-2.  Estro--'~1ed inj. in 10 cc (1L1)•ers-Carter Labs.-Distr.: Medics Pharm.* I... Labeling deficienc~ . . . 9E026.  Hi-B-Plex '~lulti ~"it. inj. in vialr (Maizel Labs.-Mfg. for Standex Labs.* I . 'Suh-pntent ... L1239.  Hi-B-Complex w'Vit. B-12 Multi \-it. inj. in .-ial~. 10 cc (f'llai:el Labs.- Distr.: Phillips Labs.* I .•. Sub-potent ... L1239.  he}••Plex Forte. 30 cc (:1laizel Labs.-Di-tr.: Key Pharmacah` I... Sub-potent . L1239. 11%falcobex 10 cc (111ai:.P1 Labs.-?41fg. for Medical Arts Supplr* ) ... Sub- potent ... L1239. "Obe,ity #8" (Plymouth Labs.-Dfstr•: Pharmecon lnc.* i... Federal Regis- ter 12'3'68 ... 8047.  Plexwin-12 Multi-Vit inj. in vials. 30 '1L (Mai:el Labs.-'11fg. for Vinston Pharm.* I ... Sub-potent ... L1239.  Resperine Tabs.. 1000's 0.1 mg.. 0.25 mg.. 1000's & bulk. 0.5 mg. bulk (Lit Drugs* ) ... Sub-potent •.. E229. E699. B1109.  Rutorbin Tabs. 20-100. Rutin 20 mg. & ascorbic acid 100 mp.1n 100S & 60-300 pkgd. in 50= (SguiLb* )...NAS-NRC Drug Efficacy Study ... All lots.  Thera-Kold Caps. (Standard Pharm.* ) : Sub•potent `super•potent: ... 2672. 'T'berapeu!tic B-Ccrmpkx 12•30 ec ( .WaisPl Labs.-Mfg. for k' estern Serum* ) . Sub-potent . . . L1239.  Vee-Plex. 30 cc (Mai-el Labs.-Mfg. for Schlicksup Drug'" )... Sub-potent . L1239. ~  Vi-Jon Hospital Brand Castor Oil. 2 oz. cathartic dose (Vi-Jon Labs.* )... Mislabeled.  Wate-On Vit. tabs. ]bld. in part "banana-three tabs. 400 units Vit. A 10.0 mg.; hesperidan 1.0 mgm; calcium pantothenate" (Sat•oy Drug & Chem.-Distr.: Fleetwood Co.* ) ... Sub-potent ... 01202. 01302. • Yellow Mercuric Oxide opthalmic ointment 1(,( & 25 NF in ?4 oz. size (Amer- ican Pharm.* ) ... Adulterated ... All lots. APPROVALS The following New Drug Applications were approved by the Food & Drug Administration between July 28 and Aug. 10. Human Products-Rx Only  Efudex (2<<, 5 i; fluorouracil ) Hofjmann-LaRoche: Actinic or solar keratoses ... sol. & cream.  Fluroplex Topical Sol (fluorouracil 1;'( ) G. S. Herbert Labs.: Actinic solar keratoses. . Geopen (sterile disodium carbenicillin) Roerig: Antibiotic.  Pliapak single & double 450 CPD Abbott: Anti-coagulant, for collection & presenYation of blood ... ol.  Pyopen (sterile disodium ca~rbenicOlin I BPrAam Pharm: Antibiotic. 80 • Mor4eting Trends Are Negro newspapers effective? Are Negroes more likel.• to notice and act on advertisements appear- ing in Negro-oriented newsl,al,er-~ than they are on ads appearing in general audience newspapers ~ They are-but only if the ads arc• placed by retailers catering exclu- sivelv to black customers or for products specifically for them. When the ad is placed b\ • a firm selling products and services of u~,e to the general public, it is more e; fecti.-e in communicating with the black consumer if it appear, in a general newspaper. Study: These are the conclusions reached by John V. Petrof, associ- ate professor of marketing at Xavier U in Cincinnati as the result of a study of \egroe~, in Atlanta who subscribe to both The Atlanta Cori- stittftion. a general newspaPer, attc,l the .-3tlattto Daily 11'orld, a \egro nes-spaper. The studv, reported in the Jortr- nal o f Retailing, attempts to test the validity of the assumption that acl- vertisements presented in black- oriented publications posses~, ar ahilitv to create a higher awarene~:~ among members of minority group. 2 ads: A total of 612 adult Ne- groes subscribing to batl7 newslxt,- pers were interviewed on the e1'e- ning that 2 advertisements featuring a sale at an establishment caterin, primarily to blacks and another e>- tablishment catering to both race- appeared in both newspaper~,. It was found that the adverti>e- ment of the firm catering primarilN to Negroes was noticed in the• Negro newspaper by 4VIC of thc sample. The same ad-vertisement drew claims of having been noticed in general newspapers b' y 2ta' , . The advertisement of the retailc-r catering to both races wa~, nc ticc-,' hy 64 ~'( of the interviewed \egrur- in the general newspaper. Thc same advertisement appearin1p in the Negro newspaper was noticed by I31„i'r l of tl ,e respondettts. I~ I, i, I , AMERICAN DRUGGiST • Sepiember 7. 10.':